Anteris Technologies Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • AVR
  • 1d-2.34%
  • 1w0.00%
  • 1m10.58%
  • 1y-8.73%
ATH
  • ATH Price$194.45
  • ATH Date2004-09-23
  • % since ATH-88.17%
  • % to ATH745.43%
ATL
  • ATL Price$0.05
  • ATL Date2011-03-14
  • % from ATL45,900.00%
  • Last Low Price$0.05
  • Last Low Date2011-03-14
  • % From Last Low45,900.00%
IPO
  • IPO Price$0.00210000
  • % Current ROI USD1,095,238.10%
  • ATH Price$194.45
  • % ROI ATH 38,889,800.00%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="AVR"]

Key Data [addtoany]

Current price $23
Sector Healthcare
Industry Medical Devices
Today's High/Low $23.7/$22.71
Volume 23,889.00
Previous Close $23.55
52 Week High/Low $24.38/$15.58
Market Cap 428,499,296.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$23
[addtoany]

Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis.
It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020.
Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity